Launching a new international cancer journal has never been an easy task by any means. It is, however, a very exciting and hazardous challenge, which can compare to an alpine expedition: once you get the idea, you think it through, and convince some friends and colleagues, all experts in their fields, and search for technical support and know-how to manage to reach the summit. Yet, the idea of an international cancer journal is such an honorable task of far-reaching consequences for the human kind that ideas alone are not enough. Careful thought, planning, commitment, and research must follow, as well as project financing and numerous debates among all stakeholders.
For Targeted Oncology, this journey lasted 3 years, 3 years of hard work, dedication and many hurdles, stumbles, storms, and doubts. Committed authors led the rope, one after another. Then, in March 2009, Targeted Oncology received recognition from peers and was accepted for indexation by PUBMED/MEDLINE and by Thomson Reuters™ (formerly ISI), for inclusion in the Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, Biotechnology Citation Index. The journal will get an Impact Factor for 2008, which will be published in July 2009.
Here stops the comparison. In a mountain expedition, you quickly return to the valley. At Targeted Oncology, with the editorial board, we prepare to stay on top and maintain excellence. 
